Suppr超能文献

心脏移植后用于排斥反应发作的永久性起搏器:预后不良的标志。

Permanent pacemaker for rejection episodes after heart transplantation: a poor prognostic sign.

作者信息

Blanche C, Czer L S, Fishbein M C, Takkenberg J J, Trento A

机构信息

Department of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

出版信息

Ann Thorac Surg. 1995 Nov;60(5):1263-6. doi: 10.1016/0003-4975(95)00612-O.

Abstract

BACKGROUND

The development of arrhythmias early or late after heart transplantation has been associated with acute and chronic rejection. This study aims to document the importance of this relationship and its value as a prognostic sign in those patients who required a permanent pacemaker for rejection episodes.

METHODS

A retrospective analysis of 158 orthotopic heart transplantations performed in 157 patients between December 1988 and April 1995 was done. The clinical course and the outcome of 6 patients who underwent insertion of a permanent pacemaker for bradyarrhythmias caused by acute or chronic allograft rejection were compared with the course and outcome of 9 patients who had pacemaker placement as a result of sinus node dysfunction not associated with rejection.

RESULTS

The mortality rate was 100% for patients whose indication for permanent pacing was severe acute or chronic rejection. Conversely, 8 of the 9 patients who underwent pacemaker placement for sinus node dysfunction not associated with rejection are long-term survivors; the one late death was due to a noncardiac cause.

CONCLUSIONS

We observed a strong relationship between bradyarrhythmias requiring a permanent pacemaker and severe acute or chronic allograft rejection. This association suggests a poor prognosis and indicates that these patients should be managed aggressively. Such management includes close immunologic surveillance for cellular and humoral rejection, increased frequency of endomyocardial biopsies and coronary angiography, and early consideration for retransplantation.

摘要

背景

心脏移植术后早期或晚期心律失常的发生与急慢性排斥反应有关。本研究旨在证实这种关系的重要性及其作为需要因排斥反应发作而植入永久起搏器的患者预后指标的价值。

方法

对1988年12月至1995年4月期间157例患者进行的158例原位心脏移植进行回顾性分析。将6例因急性或慢性同种异体移植排斥反应导致的缓慢性心律失常而植入永久起搏器的患者的临床病程和结局,与9例因与排斥反应无关的窦房结功能障碍而植入起搏器的患者的病程和结局进行比较。

结果

因严重急性或慢性排斥反应而进行永久起搏的患者死亡率为100%。相反,9例因与排斥反应无关的窦房结功能障碍而接受起搏器植入的患者中有8例是长期存活者;1例晚期死亡是由非心脏原因导致的。

结论

我们观察到需要永久起搏器的缓慢性心律失常与严重急性或慢性同种异体移植排斥反应之间存在密切关系。这种关联提示预后不良,并表明应对这些患者进行积极治疗。这种治疗包括对细胞和体液排斥反应进行密切的免疫监测、增加心内膜活检和冠状动脉造影的频率,以及尽早考虑再次移植。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验